#begin document (nw/wsj/20/wsj_2098); part 000
nw/wsj/20/wsj_2098   0    0             Oncor   NNP        (TOP(S(NP(NP*        -    -   -   -   (ORG*         *             *   -
nw/wsj/20/wsj_2098   0    1              Inc.   NNP                    *)       -    -   -   -       *)        *             *   -
nw/wsj/20/wsj_2098   0    2                 ,     ,                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0    3      Gaithersburg   NNP              (NP(NP*)       -    -   -   -    (GPE)        *             *   -
nw/wsj/20/wsj_2098   0    4                 ,     ,                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0    5               Md.   NNP                (NP*))       -    -   -   -    (GPE)        *             *   -
nw/wsj/20/wsj_2098   0    6                 ,     ,                    *)       -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0    7              said   VBD                 (VP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0    8                it   PRP          (SBAR(S(NP*)       -    -   -   -       *    (ARG0*)            *   -
nw/wsj/20/wsj_2098   0    9          received   VBD                 (VP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   10          approval    NN              (NP(NP*)       -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   11              from    IN                 (PP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   12               the    DT                 (NP*        -    -   -   -   (ORG*         *             *   -
nw/wsj/20/wsj_2098   0   13              U.S.   NNP                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   14              Food   NNP                (NML*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   15               and    CC                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   16              Drug   NNP                    *)       -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   17    Administration   NNP                   *))       -    -   -   -       *)        *             *   -
nw/wsj/20/wsj_2098   0   18                to    TO               (S(VP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   19            market    VB                 (VP*    market  01   1   -       *       (V*)            *   -
nw/wsj/20/wsj_2098   0   20                 a    DT              (NP(NP*        -    -   -   -       *    (ARG1*        (ARG0*   -
nw/wsj/20/wsj_2098   0   21           genetic    JJ                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   22              test    NN                    *)       -    -   -   -       *         *             *)  -
nw/wsj/20/wsj_2098   0   23              that   WDT          (SBAR(WHNP*)       -    -   -   -       *         *      (R-ARG0*)  -
nw/wsj/20/wsj_2098   0   24              will    MD               (S(VP*        -    -   -   -       *         *    (ARGM-MOD*)  -
nw/wsj/20/wsj_2098   0   25            assist    VB                 (VP*    assist  01   2   -       *         *           (V*)  -
nw/wsj/20/wsj_2098   0   26                in    IN                 (PP*        -    -   -   -       *         *        (ARG2*   -
nw/wsj/20/wsj_2098   0   27         diagnosis    NN              (NP(NP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   28               and    CC                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   29         treatment    NN                    *)       -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   30                of    IN                 (PP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   31          leukemia    NN              (NP(NP*)       -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   32               and    CC                    *        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   33             lymph    NN                 (NP*        -    -   -   -       *         *             *   -
nw/wsj/20/wsj_2098   0   34            cancer    NN   *))))))))))))))))))       -    -   -   -       *         *)            *)  -
nw/wsj/20/wsj_2098   0   35                 .     .                   *))       -    -   -   -       *         *             *   -

nw/wsj/20/wsj_2098   0    0              The    DT    (TOP(SINV(S(NP*          -    -   -   -          *       (ARG1*         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    1                B   NNP      (NML(NML(NML*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    2                /   SYM                  *          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    3                T   NNP                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    4             gene    NN                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    5    rearrangement    NN                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    6             test    NN                  *)         -    -   -   -          *            *)        *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    7               is   VBZ               (VP*          be  01   -   -          *          (V*)        *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    8             more   RBR        (ADJP(ADJP*          -    -   -   -          *       (ARG2*         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0    9         accurate    JJ                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   10             than    IN               (PP*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   11         existing   VBG               (NP*       exist  01   -   -          *            *       (V*)       *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   12            tests   NNS                *)))         -    -   -   -          *            *)   (ARG1*)       *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   13              for    IN               (PP*          -    -   -   -          *   (ARGM-PRP*         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   14       diagnosing   VBG             (S(VP*    diagnose  01   -   -          *            *         *      (V*)        *        *         *        *   -
nw/wsj/20/wsj_2098   0   15              the    DT         (NP(NP(NP*          -    -   -   -          *            *         *   (ARG2*         *        *         *        *   -
nw/wsj/20/wsj_2098   0   16             type    NN                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   17               of    IN               (PP*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   18           cancer    NN             (NP*)))         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   19                ,     ,                  *          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   20          whether    IN        (SBAR(SBAR*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   21               it   PRP             (S(NP*)         -    -   -   -          *            *         *        *    (ARG1*)       *         *        *   -
nw/wsj/20/wsj_2098   0   22              has   VBZ               (VP*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   23           spread   VBN            (VP*))))     spread  02   2   -          *            *         *        *       (V*)       *         *        *   -
nw/wsj/20/wsj_2098   0   24               or    CC                  *          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   25          whether    IN             (SBAR*          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   26            there    EX             (S(NP*)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   27               is   VBZ               (VP*          be  02   -   -          *            *         *        *         *      (V*)        *        *   -
nw/wsj/20/wsj_2098   0   28                a    DT            (NP(NP*          -    -   -   -          *            *         *        *         *   (ARG1*    (ARG1*        *   -
nw/wsj/20/wsj_2098   0   29       recurrence    NN                  *)         -    -   -   -          *            *         *        *         *        *         *)       *   -
nw/wsj/20/wsj_2098   0   30        following   VBG               (VP*      follow  01   -   -          *            *         *        *         *        *       (V*)       *   -
nw/wsj/20/wsj_2098   0   31        treatment    NN   (NP*)))))))))))))         -    -   -   -          *            *)        *        *)        *        *)   (ARG2*)       *   -
nw/wsj/20/wsj_2098   0   32                ,     ,                  *          -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   33             said   VBD               (VP*)        say  01   -   -          *            *         *        *         *        *         *      (V*)  -
nw/wsj/20/wsj_2098   0   34            Oncor   NNP           (NP(NML*          -    -   -   -       (ORG)           *         *        *         *        *         *   (ARG0*   -
nw/wsj/20/wsj_2098   0   35        President   NNP                  *)         -    -   -   -          *            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   36          Stephen   NNP                  *          -    -   -   -   (PERSON*            *         *        *         *        *         *        *   -
nw/wsj/20/wsj_2098   0   37           Turner   NNP                  *)         -    -   -   -          *)           *         *        *         *        *         *        *)  -
nw/wsj/20/wsj_2098   0   38                .     .                 *))         -    -   -   -          *            *         *        *         *        *         *        *   -

nw/wsj/20/wsj_2098   0    0            Mr.   NNP   (TOP(S(NP*        -    -   -   -          *   (ARG0*             *             *   -
nw/wsj/20/wsj_2098   0    1         Turner   NNP            *)       -    -   -   -    (PERSON)       *)            *             *   -
nw/wsj/20/wsj_2098   0    2           said   VBD         (VP*       say  01   -   -          *      (V*)            *             *   -
nw/wsj/20/wsj_2098   0    3            the    DT  (SBAR(S(NP*        -    -   -   -          *   (ARG1*        (ARG1*        (ARG1*   -
nw/wsj/20/wsj_2098   0    4           test    NN            *)       -    -   -   -          *        *             *)            *)  -
nw/wsj/20/wsj_2098   0    5      initially    RB    (VP(ADVP*)       -    -   -   -          *        *    (ARGM-MNR*)            *   -
nw/wsj/20/wsj_2098   0    6           will    MD         (VP*        -    -   -   -          *        *    (ARGM-MOD*)            *   -
nw/wsj/20/wsj_2098   0    7             be    VB         (VP*        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0    8           used   VBN         (VP*       use  01   -   -          *        *           (V*)            *   -
nw/wsj/20/wsj_2098   0    9             in    IN         (PP*        -    -   -   -          *        *    (ARGM-MNR*             *   -
nw/wsj/20/wsj_2098   0   10    conjunction    NN      (NP(NP*)       -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   11           with    IN         (PP*        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   12       biopsies   NNS      (NP(NP*)       -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   13            and    CC            *        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   14          other    JJ         (NP*        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   15          tests   NNS     *))))))))       -    -   -   -          *        *             *)            *   -
nw/wsj/20/wsj_2098   0   16              ,     ,            *        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   17            but    CC            *        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   18     eventually    RB       (ADVP*)       -    -   -   -          *        *             *    (ARGM-TMP*)  -
nw/wsj/20/wsj_2098   0   19          might    MD         (VP*        -    -   -   -          *        *             *    (ARGM-MOD*)  -
nw/wsj/20/wsj_2098   0   20         become    VB         (VP*    become  01   -   -          *        *             *           (V*)  -
nw/wsj/20/wsj_2098   0   21            the    DT      (NP(NP*        -    -   -   -          *        *             *        (ARG2*   -
nw/wsj/20/wsj_2098   0   22      benchmark    NN            *)       -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   23            for    IN         (PP*        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   24          tumor    NN         (NP*        -    -   -   -          *        *             *             *   -
nw/wsj/20/wsj_2098   0   25       analysis    NN    *)))))))))       -    -   -   -          *        *)            *             *)  -
nw/wsj/20/wsj_2098   0   26              .     .           *))       -    -   -   -          *        *             *             *   -

nw/wsj/20/wsj_2098   0    0             Mr.   NNP   (TOP(S(NP*      -    -   -   -          *   (ARG0*             *   -
nw/wsj/20/wsj_2098   0    1          Turner   NNP            *)     -    -   -   -    (PERSON)       *)            *   -
nw/wsj/20/wsj_2098   0    2            said   VBD         (VP*     say  01   -   -          *      (V*)            *   -
nw/wsj/20/wsj_2098   0    3             the    DT  (SBAR(S(NP*      -    -   -   -          *   (ARG1*        (ARG1*   -
nw/wsj/20/wsj_2098   0    4            test    NN            *)     -    -   -   -          *        *             *)  -
nw/wsj/20/wsj_2098   0    5            will    MD         (VP*      -    -   -   -          *        *    (ARGM-MOD*)  -
nw/wsj/20/wsj_2098   0    6              be    VB         (VP*      -    -   -   -          *        *             *   -
nw/wsj/20/wsj_2098   0    7         shipped   VBN         (VP*    ship  01   -   -          *        *           (V*)  -
nw/wsj/20/wsj_2098   0    8              in    IN         (PP*      -    -   -   -          *        *    (ARGM-TMP*   -
nw/wsj/20/wsj_2098   0    9             45     CD         (NP*      -    -   -   -     (DATE*        *             *   -
nw/wsj/20/wsj_2098   0   10            days   NNS           *))     -    -   -   -          *)       *             *)  -
nw/wsj/20/wsj_2098   0   11              to    IN         (PP*      -    -   -   -          *        *        (ARG2*   -
nw/wsj/20/wsj_2098   0   12       hospitals   NNS      (NP(NP*)     -    -   -   -          *        *             *   -
nw/wsj/20/wsj_2098   0   13             and    CC            *      -    -   -   -          *        *             *   -
nw/wsj/20/wsj_2098   0   14        clinical    JJ         (NP*      -    -   -   -          *        *             *   -
nw/wsj/20/wsj_2098   0   15    laboratories   NNS    *)))))))))     -    -   -   -          *        *)            *)  -
nw/wsj/20/wsj_2098   0   16               .     .           *))     -    -   -   -          *        *             *   -

nw/wsj/20/wsj_2098   0    0             Dr.   NNP    (TOP(S(NP(NP*        -    -   -   -          *   (ARG0*             *         *        *   -
nw/wsj/20/wsj_2098   0    1         Wyndham   NNP                *        -    -   -   -   (PERSON*        *             *         *        *   -
nw/wsj/20/wsj_2098   0    2          Wilson   NNP                *)       -    -   -   -          *)       *             *         *        *   -
nw/wsj/20/wsj_2098   0    3               ,     ,                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    4               a    DT          (NP(NP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    5          cancer    NN            (NML*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    6       treatment    NN                *)       -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    7      specialist    NN                *)       -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    8              at    IN             (PP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0    9             the    DT             (NP*        -    -   -   -      (ORG*        *             *         *        *   -
nw/wsj/20/wsj_2098   0   10        National   NNP                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   11          Cancer   NNP                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   12       Institute   NNP              *)))       -    -   -   -          *)       *             *         *        *   -
nw/wsj/20/wsj_2098   0   13               ,     ,                *)       -    -   -   -          *        *)            *         *        *   -
nw/wsj/20/wsj_2098   0   14            said   VBD             (VP*       say  01   -   -          *      (V*)            *         *        *   -
nw/wsj/20/wsj_2098   0   15             the    DT      (SBAR(S(NP*        -    -   -   -          *   (ARG1*        (ARG1*         *        *   -
nw/wsj/20/wsj_2098   0   16            test    NN                *)       -    -   -   -          *        *             *)        *        *   -
nw/wsj/20/wsj_2098   0   17              is   VBZ          (VP(VP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   18          widely    RB           (ADVP*)       -    -   -   -          *        *    (ARGM-MNR*)        *        *   -
nw/wsj/20/wsj_2098   0   19            used   VBN             (VP*       use  01   -   -          *        *           (V*)        *        *   -
nw/wsj/20/wsj_2098   0   20              in    IN             (PP*        -    -   -   -          *        *    (ARGM-LOC*         *        *   -
nw/wsj/20/wsj_2098   0   21        research    NN             (NP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   22         centers   NNS             *))))       -    -   -   -          *        *             *)        *        *   -
nw/wsj/20/wsj_2098   0   23             but    CC                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   24              is   VBZ             (VP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   25             n't    RB                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   26          having   VBG             (VP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   27               a    DT             (NP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   28           major    JJ                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   29          impact    NN                *)       -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   30         because    IN           (SBAR*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   31              it   PRP           (S(NP*)       -    -   -   -          *        *             *    (ARG1*)       *   -
nw/wsj/20/wsj_2098   0   32              is   VBZ             (VP*        be  01   -   -          *        *             *       (V*)       *   -
nw/wsj/20/wsj_2098   0   33            only    RB      (ADJP(ADVP*        -    -   -   -          *        *             *    (ARG2*        *   -
nw/wsj/20/wsj_2098   0   34    occasionally    RB                *)       -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   35          useful    JJ                *        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   36              in    IN             (PP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   37        choosing   VBG           (S(VP*    choose  01   -   -          *        *             *         *      (V*)  -
nw/wsj/20/wsj_2098   0   38             the    DT             (NP*        -    -   -   -          *        *             *         *   (ARG1*   -
nw/wsj/20/wsj_2098   0   39            most   JJS           (ADJP*        -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   40       effective    JJ                *)       -    -   -   -          *        *             *         *        *   -
nw/wsj/20/wsj_2098   0   41       treatment    NN   *))))))))))))))       -    -   -   -          *        *)            *         *)       *)  -
nw/wsj/20/wsj_2098   0   42               .     .               *))       -    -   -   -          *        *             *         *        *   -

nw/wsj/20/wsj_2098   0    0            But    CC             (TOP(S(S*           -    -   -   -          *    (ARGM-DIS*)       *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    1            the    DT                  (NP*           -    -   -   -          *             *   (ARG1*   (ARG0*            *            *         *        *   -
nw/wsj/20/wsj_2098   0    2           test    NN                     *)          -    -   -   -          *             *        *)       *)           *            *         *        *   -
nw/wsj/20/wsj_2098   0    3            may    MD                  (VP*           -    -   -   -          *    (ARGM-MOD*)       *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    4          prove    VB                  (VP*        prove  01   -   -          *           (V*)       *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    5             to    TO                (S(VP*           -    -   -   -          *        (ARG1*        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    6             be    VB                  (VP*           be  01   -   -          *             *      (V*)       *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    7           more   RBR                (ADJP*           -    -   -   -          *             *   (ARG2*        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    8      sensitive    JJ                     *           -    -   -   -          *             *        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0    9             in    IN                  (PP*           -    -   -   -          *             *        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0   10    determining   VBG                (S(VP*    determine  01   -   -          *             *        *      (V*)           *            *         *        *   -
nw/wsj/20/wsj_2098   0   11        whether    IN                (SBAR*           -    -   -   -          *             *        *   (ARG1*            *            *         *        *   -
nw/wsj/20/wsj_2098   0   12              a    DT                (S(NP*           -    -   -   -          *             *        *        *       (ARG1*       (ARG1*         *        *   -
nw/wsj/20/wsj_2098   0   13          tumor    NN                     *)          -    -   -   -          *             *        *        *            *)           *)        *        *   -
nw/wsj/20/wsj_2098   0   14            has   VBZ                  (VP*           -    -   -   -          *             *        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0   15         spread   VBN                  (VP*       spread  02   2   -          *             *        *        *          (V*)           *         *        *   -
nw/wsj/20/wsj_2098   0   16             or    CC                     *           -    -   -   -          *             *        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0   17       returned   VBN                     *       return  01   -   -          *             *        *        *            *          (V*)        *        *   -
nw/wsj/20/wsj_2098   0   18      following   VBG                  (PP*       follow  01   -   -          *             *        *        *   (ARGM-TMP*   (ARGM-TMP*       (V*)       *   -
nw/wsj/20/wsj_2098   0   19      treatment    NN   (NP*))))))))))))))))          -    -   -   -          *             *)       *)       *)           *)           *)   (ARG2*)       *   -
nw/wsj/20/wsj_2098   0   20              ,     ,                     *           -    -   -   -          *             *        *        *            *            *         *        *   -
nw/wsj/20/wsj_2098   0   21            Dr.   NNP                  (NP*           -    -   -   -          *             *        *        *            *            *         *   (ARG0*   -
nw/wsj/20/wsj_2098   0   22         Wilson   NNP                     *)          -    -   -   -    (PERSON)            *        *        *            *            *         *        *)  -
nw/wsj/20/wsj_2098   0   23           said   VBD                  (VP*)         say  01   -   -          *             *        *        *            *            *         *      (V*)  -
nw/wsj/20/wsj_2098   0   24              .     .                    *))          -    -   -   -          *             *        *        *            *            *         *        *   -

nw/wsj/20/wsj_2098   0    0        ``    ``         (TOP(S*      -    -   -   -   *             *      *      *         *         *   -
nw/wsj/20/wsj_2098   0    1        We   PRP          (S(NP*)     -    -   -   -   *        (ARG0*)     *      *         *    (ARG1*   -
nw/wsj/20/wsj_2098   0    2        do   VBP            (VP*      -    -   -   -   *             *      *      *         *         *   -
nw/wsj/20/wsj_2098   0    3       n't    RB               *      -    -   -   -   *    (ARGM-NEG*)     *      *         *         *   -
nw/wsj/20/wsj_2098   0    4      know    VB            (VP*    know  01   1   -   *           (V*)     *      *         *         *   -
nw/wsj/20/wsj_2098   0    5       yet    RB          (ADVP*)     -    -   -   -   *    (ARGM-TMP*)     *      *         *         *   -
nw/wsj/20/wsj_2098   0    6       how   WRB   (SBAR(WHADVP*      -    -   -   -   *        (ARG1*      *      *    (ARG2*         *   -
nw/wsj/20/wsj_2098   0    7    useful    JJ         (ADJP*))     -    -   -   -   *             *      *      *         *)        *   -
nw/wsj/20/wsj_2098   0    8        it   PRP          (S(NP*)     -    -   -   -   *             *      *      *    (ARG1*)        *   -
nw/wsj/20/wsj_2098   0    9        's   VBZ            (VP*      be  03   -   -   *             *    (V*)     *         *         *   -
nw/wsj/20/wsj_2098   0   10     going   VBG            (VP*      go  04   -   -   *             *      *    (V*)        *         *   -
nw/wsj/20/wsj_2098   0   11        to    TO          (S(VP*      -    -   -   -   *             *      *      *         *         *   -
nw/wsj/20/wsj_2098   0   12        be    VB   (VP*))))))))))     be  01   -   -   *             *)     *      *       (V*)        *)  -
nw/wsj/20/wsj_2098   0   13         ,     ,               *      -    -   -   -   *             *      *      *         *         *   -
nw/wsj/20/wsj_2098   0   14        ''    ''               *      -    -   -   -   *             *      *      *         *         *   -
nw/wsj/20/wsj_2098   0   15        he   PRP            (NP*)     -    -   -   -   *             *      *      *         *    (ARG0*)  -
nw/wsj/20/wsj_2098   0   16      said   VBD            (VP*)    say  01   -   -   *             *      *      *         *       (V*)  -
nw/wsj/20/wsj_2098   0   17         .     .              *))     -    -   -   -   *             *      *      *         *         *   -

nw/wsj/20/wsj_2098   0    0        Oncor    NNP    (TOP(S(S(NP(NP*)        -    -   -   -        (ORG)  (ARG0*             *            *        *   -
nw/wsj/20/wsj_2098   0    1            ,      ,                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    2            a     DT            (NP(NP*         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    3          six     CD         (ADJP(NML*         -    -   -   -      (DATE*        *             *            *        *   -
nw/wsj/20/wsj_2098   0    4           -    HYPH                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    5         year     NN                  *)        -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    6           -    HYPH                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    7          old     JJ                  *)        -    -   -   -           *)       *             *            *        *   -
nw/wsj/20/wsj_2098   0    8    developer     NN                  *)        -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0    9           of     IN               (PP*         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   10      genetic     JJ               (NP*         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   11      medical     JJ                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   12        tests    NNS                *)))        -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   13            ,      ,                  *)        -    -   -   -           *        *)            *            *        *   -
nw/wsj/20/wsj_2098   0   14     projects    VBZ               (VP*    project  02   5   -           *      (V*)            *            *        *   -
nw/wsj/20/wsj_2098   0   15         that     IN             (SBAR*         -    -   -   -           *   (ARG1*             *            *        *   -
nw/wsj/20/wsj_2098   0   16          the     DT             (S(NP*         -    -   -   -           *        *        (ARG0*            *        *   -
nw/wsj/20/wsj_2098   0   17       cancer     NN                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   18         test     NN                  *)        -    -   -   -           *        *             *)           *        *   -
nw/wsj/20/wsj_2098   0   19         will     MD               (VP*         -    -   -   -           *        *    (ARGM-MOD*)           *        *   -
nw/wsj/20/wsj_2098   0   20         help     VB               (VP*       help  01   -   -           *        *           (V*)           *        *   -
nw/wsj/20/wsj_2098   0   21           it    PRP               (NP*)        -    -   -   -           *        *        (ARG2*)      (ARG0*)       *   -
nw/wsj/20/wsj_2098   0   22           to     TO             (S(VP*         -    -   -   -           *        *        (ARG1*            *        *   -
nw/wsj/20/wsj_2098   0   23         post     VB               (VP*       post  01   -   -           *        *             *          (V*)       *   -
nw/wsj/20/wsj_2098   0   24          its   PRP$               (NP*         -    -   -   -           *        *             *       (ARG1*        *   -
nw/wsj/20/wsj_2098   0   25        first     JJ              (NML*         -    -   -   -    (ORDINAL)       *             *            *        *   -
nw/wsj/20/wsj_2098   0   26           -    HYPH                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   27         ever     RB                  *)        -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   28       profit     NN                  *)    profit   -   1   -           *        *             *            *)       *   -
nw/wsj/20/wsj_2098   0   29       during     IN               (PP*         -    -   -   -           *        *             *   (ARGM-TMP*        *   -
nw/wsj/20/wsj_2098   0   30          the     DT            (NP(NP*         -    -   -   -      (DATE*        *             *            *        *   -
nw/wsj/20/wsj_2098   0   31        first     JJ                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   32      quarter     NN                  *)        -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   33           of     IN               (PP*         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   34        1990      CD   (NP*)))))))))))))        -    -   -   -           *)       *)            *)           *)       *   -
nw/wsj/20/wsj_2098   0   35            ,      ,                  *         -    -   -   -           *        *             *            *        *   -
nw/wsj/20/wsj_2098   0   36          Mr.    NNP               (NP*         -    -   -   -           *        *             *            *   (ARG0*   -
nw/wsj/20/wsj_2098   0   37       Turner    NNP                  *)        -    -   -   -     (PERSON)       *             *            *        *)  -
nw/wsj/20/wsj_2098   0   38         said    VBD               (VP*)       say  01   -   -           *        *             *            *      (V*)  -
nw/wsj/20/wsj_2098   0   39            .      .                 *))        -    -   -   -           *        *             *            *        *   -

nw/wsj/20/wsj_2098   0    0          The    DT  (TOP(S(S(NP*         -    -   -   -         *        (ARG0*   (ARG0*    (ARG1*   -
nw/wsj/20/wsj_2098   0    1      company    NN             *)        -    -   -   -         *             *)       *)        *   -
nw/wsj/20/wsj_2098   0    2         will    MD       (VP(VP*         -    -   -   -         *    (ARGM-MOD*)       *         *   -
nw/wsj/20/wsj_2098   0    3       charge    VB          (VP*     charge  01   -   -         *           (V*)       *         *   -
nw/wsj/20/wsj_2098   0    4            $     $          (NP*         -    -   -   -         *        (ARG1*        *         *   -
nw/wsj/20/wsj_2098   0    5          35     CD             *)        -    -   -   -    (MONEY)            *)       *         *   -
nw/wsj/20/wsj_2098   0    6          for    IN          (PP*         -    -   -   -         *        (ARG3*        *         *   -
nw/wsj/20/wsj_2098   0    7            a    DT          (NP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0    8         test    NN          *))))        -    -   -   -         *             *)       *         *   -
nw/wsj/20/wsj_2098   0    9          and    CC             *         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   10     projects   VBZ          (VP*    project  02   5   -         *             *      (V*)        *   -
nw/wsj/20/wsj_2098   0   11        about    IN       (NP(NP*         -    -   -   -   (MONEY*             *   (ARG1*         *   -
nw/wsj/20/wsj_2098   0   12            $     $          (QP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   13           2     CD             *         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   14      million    CD            *))        -    -   -   -         *)            *        *         *   -
nw/wsj/20/wsj_2098   0   15           in    IN          (PP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   16      revenue    NN         (NP*))        -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   17         from    IN          (PP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   18          the    DT          (NP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   19         test    NN            *))        -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   20       during    IN          (PP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   21          the    DT       (NP(NP*         -    -   -   -    (DATE*             *        *         *   -
nw/wsj/20/wsj_2098   0   22        first    JJ             *         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   23          12     CD             *         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   24       months   NNS             *)        -    -   -   -         *)            *        *         *   -
nw/wsj/20/wsj_2098   0   25           of    IN          (PP*         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   26    marketing    NN   (NP*))))))))        -    -   -   -         *             *        *)        *)  -
nw/wsj/20/wsj_2098   0   27            ,     ,             *         -    -   -   -         *             *        *         *   -
nw/wsj/20/wsj_2098   0   28           he   PRP          (NP*)        -    -   -   -         *             *        *    (ARG0*)  -
nw/wsj/20/wsj_2098   0   29         said   VBD          (VP*)       say  01   -   -         *             *        *       (V*)  -
nw/wsj/20/wsj_2098   0   30            .     .            *))        -    -   -   -         *             *        *         *   -

#end document
